Form 4: Roivant CFO Richard Pulik Sells Shares for Tax Obligations
Insider Transaction Report
Roivant Sciences CFO Richard Pulik disposed of 1,235 common shares at $11.72 each to cover tax withholding on vested restricted stock units.
Summary
- Richard Pulik, Chief Financial Officer (CFO) of Roivant Sciences Ltd. (ROIV), reported a transaction on August 20, 2025.
- The transaction involved the disposition of 1,235 common shares.
- The shares were disposed of at a price of $11.72 per share.
- This disposition was a 'net settlement' by the Issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of previously granted Restricted Stock Units (RSUs).
- Following this reported transaction, Mr. Pulik directly beneficially owns 396,318 common shares.
Sentiment
Score: 5
Explanation: The transaction is a routine disposition of shares for tax withholding purposes upon RSU vesting, which is a common and expected event for executive compensation and generally considered neutral in terms of company performance or outlook.
Positives
- The transaction indicates the vesting of Restricted Stock Units (RSUs) previously granted to the CFO, which is a form of compensation and a positive for the executive.
Negatives
- The disposition of shares, while for tax purposes, results in a reduction of the CFO's direct shareholding in the company.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This insider transaction report is specific to Roivant Sciences Ltd. and its CFO, Richard Pulik. It does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: The transaction represents a minor reduction in insider ownership, but it is a routine event for tax purposes and is unlikely to have a significant impact on shareholder sentiment or share price.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 08/20/2025 | Date of the transaction (disposition of common shares). |
| 08/22/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed. |
Recommendation
holdThis Form 4 reports a routine disposition of shares by the CFO to cover tax obligations associated with RSU vesting. Such transactions are common and do not typically signal a change in management's outlook or the company's fundamentals, thus warranting a 'hold' recommendation based solely on this filing.
Keywords
Roivant Sciences, ROIV, Richard Pulik, CFO, Form 4, Insider Transaction, Share Disposition, RSU Vesting, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.